NLRP3 and early-onset autosomal dominant Alzheimer disease: In animal models of other neuroinflammatory-related conditions such as Alzheimer’s disease and stroke, knock-down or knock-out of NLRP3 has been shown to decrease neuroinflammation as well as improve functional outcomes [62, 63].